Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study

Journal of the American Academy of Dermatology

Volumn 69, Issue 4, 2013, Pages 523-529

  Jókai, Hajnalka ^a   Szakonyi, József ^a   Kontár, Orsolya ^a   Marschalkó, Márta ^a   Szalai, Klára ^a   Kárpáti, Sarolta ^a   Holló, Péter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

arterial intima media thickness; atherosclerosis; cardiovascular risk; high resolution B mode ultrasonography; psoriasis vulgaris; tumor necrosis factor alfa inhibitor

Indexed keywords

ADALIMUMAB; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BIGUANIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETANERCEPT; ETRETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; NITRATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; DERMATOLOGY LIFE QUALITY INDEX; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; OBESITY; PHOTOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; SMOKING;

(18)F-FLUORO-DEOXYGLUCOSE; ARTERIAL INTIMA-MEDIA THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHY; CT; FDG; HIGH-RESOLUTION B-MODE ULTRASONOGRAPHY; IMT; INTIMA-MEDIA THICKNESS; PASI; PET; POSITRON EMISSION TOMOGRAPHY; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; T-HELPER CELL; TH; TNF; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALFA INHIBITOR;

ADULT; AGED; BRACHIAL ARTERY; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSORIASIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY, INTERVENTIONAL; YOUNG ADULT;

EID: 84884357683     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.06.019     Document Type: Article

References (50)

1. A. Kuek, B.L. Hazleman, and A.J. Ostör Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution Postgrad Med J 83 2007 251 260
2. M.N. Di Minno, S. Iervolino, R. Peluso, R. Scarpa, and G. Di Minno Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs Arterioscler Thromb Vasc Biol 31 2011 705 712
3. L.S. Tam, E.K. Li, Q. Shang, B. Tomlinson, M. Li, and Y.Y. Leung Tumor necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study Ann Rheum Dis 70 2011 705 706
4. D. Siegel, S. Devaraj, A. Mitra, S.P. Raychaudhuri, S.K. Raychaudhuri, and I. Jialal Inflammation, atherosclerosis, and psoriasis Clin Rev Allergy Immunol 44 2013 194 204
5. N.N. Mehta, Y.D. Yu, B. Saboury, N. Foroughi, P. Krishnamoorthy, and A. Raper Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT): a pilot study Arch Dermatol 147 2011 1031 1039
6. F. Späh Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach Br J Dermatol 159 Suppl 2008 10 17
7. K. Reich The concept of psoriasis as a systemic inflammation: implications for disease management J Eur Acad Dermatol Venereol 26 2012 3 11
8. W.H. Boehncke, S. Boehncke, and M.P. Schön Managing comorbid disease in patients with psoriasis BMJ 340 2010 b5666
9. L. Mallbris, O. Akre, F. Granath, L. Yin, B. Lindelöf, and A. Ekbom Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients Eur J Epidemiol 19 2004 225 230
10. J.M. Gelfand, A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741
11. D.D. Balci, A. Balci, S. Karazincir, E. Ucar, U. Iyigun, and F. Yalcin Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis J Eur Acad Dermatol Venereol 23 2009 1 6
12. B.E. Strober, J. Clay Cather, D. Cohen, J.J. Crowley, K.B. Gordon, and A.B. Gottlieb A Delphi consensus approach to challenging case scenarios in moderate-to-severe psoriasis: part 1 Dermatol Ther (Heidelb) 2 2012 1 24
13. W. Bilsborough, H. Keen, A. Taylor, G.J. O'Driscoll, L. Arnolda, and D.J. Green Anti-tumor necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis Rheumatol Int 26 2006 1125 1131
14. D. Hürlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, and O. Distler Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
15. A. Ferrante, A.R. Giardina, F. Ciccia, G. Parrinello, G. Licata, and G. Avellone Long-term anti-tumor necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis Rheumatol Int 30 2009 193 198
16. F. Del Porto, B. Laganà, S. Lai, I. Nofroni, F. Tinti, and M. Vitale Response to anti-tumor necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis Rheumatology 46 2007 1111 1115
17. S.A. Mazlan, M.S. bin Mohamed Said, H. Hussein, K. binti Shamsuddin, S.A. Shah, and H. Basri A study of intima media thickness and their cardiovascular risk factors in patients with psoriatic arthritis Acta Medica (Hradec Kralove) 52 2009 107 116
18. K.M. Mäki-Petäjä, M. Elkhawad, J. Cheriyan, F.R. Joshi, A.J.K. Östör, and F.C. Hall Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis Circulation 126 2012 2473 2480
19. K. Angel, S.A. Provan, M.K. Fagerhol, P. Mowinckel, T.K. Kvien, and D. Atar Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study Am J Hypertens 25 2012 644 650
20. T.K. Lim, E. Lim, G. Dwivedi, J. Kooner, and R. Senior Normal value of carotid intima-media thickness-a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound J Am Soc Echocardiogr 21 2008 112 116
21. H. Maradit-Kremers, M. Icen, F.C. Ernste, R.A. Dierkhising, and M.T. McEvoy Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study J Eur Acad Dermatol Venereol 26 2012 336 343
22. T. Lotti, J. Hercogova, and F. Prignano The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Dermatol Ther 23 2010 119 122
23. A. Anogeianaki, D. Angelucci, E. Cianchetti, M. D'Alessandro, G. Maccauro, and A. Saggini Atherosclerosis: a classic inflammatory disease Int J Immunopathol Pharmacol 24 2011 817 825
24. M. Drakopoulou, K. Toutouzas, A. Michelongona, D. Tousoulis, and C. Stefanadis Vulnerable plaque and inflammation: potential clinical strategies Curr Pharm Des 17 2011 4190 4209
25. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
26. R.V. Patel, M.L. Shelling, S. Prodanovich, D.G. Federman, and R.S. Kirsner Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature J Gen Intern Med 26 2011 1036 1049
27. I.L. Tablazon, A. Al-Dabagh, S.A. Davis, and S.R. Feldman Risk of cardiovascular disorders in psoriasis patients: current and future Am J Clin Dermatol 14 2013 1 7
28. A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, A.B. Troxel, and J.M. Gelfand Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol 55 2006 829 835
29. J. Bełtowski Leptin and the regulation of endothelial function in physiological and pathological conditions Clin Exp Pharmacol Physiol 39 2012 168 178
30. S. Prodanovich, R.S. Kirsner, J.D. Kravetz, F. Ma, L. Martinez, and D.G. Federman Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality Arch Dermatol 145 2009 700 703
31. A.W. Armstrong, C.T. Harskamp, L. Ledo, J.H. Rogers, and E.J. Armstrong Coronary artery disease in patients with psoriasis referred for coronary angiography Am J Cardiol 109 2012 976 980
32. S. El-Mongy, H. Fathy, A. Abdelaziz, E. Omran, S. George, and N. Neseem Subclinical atherosclerosis in patients with chronic psoriasis: a potential association J Eur Acad Dermatol Venereol 24 2010 661 666
33. S. Arias-Santiago, J. Orgaz-Molina, L. Castellote-Caballero, M.Á. Arrabal-Polo, S. García-Rodriguez, and R. Perandrés-López Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis Eur J Dermatol 22 2012 337 344
34. G. Mazzoccoli, I. Notarsanto, G.D. de Pinto, M.P. Dagostino, A. De Cata, and G. D'Alessandro Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients Intern Emerg Med 5 2010 495 500
35. H.J. Wu, J. Hao, S.Q. Wang, B.L. Jin, and X.B. Chen Protective effects of ligustrazine on TNF-α-induced endothelial dysfunction Eur J Pharmacol 674 2012 365 369
36. C.J. Lyon, R.E. Law, and W.A. Hsueh Minireview: adiposity, inflammation, and atherogenesis Endocrinology 144 2003 2195 2200
37. J.K. Sethi, and G.S. Hotamisligil The role of TNFα in adipocyte metabolism Semin Cell Dev Biol 10 1999 19 29
38. A. Kabłak-Ziembicka, T. Przewłocki, E. Stȩ pień, P. Pienia̧zek, D. Rzeźnik, and D. Sliwiak Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis Kardiol Pol 69 2011 1024 1031
39. N. Sattar, D.W. McCarey, H. Capell, and I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
40. A.D. Gepner, J.G. Keevil, R.A. Wyman, C.E. Korcarz, S.E. Aeschlimann, and K.L. Busse Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction J Am Soc Echocardiogr 19 2006 1170 1174
41. M. Cobble, and B. Bale Carotid intima-media thickness: knowledge and application to everyday practice Postgrad Med 122 2010 10 18
42. B. Enany, A.K. El Zohiery, R. Elhilaly, and T. Badr Carotid intima-media thickness and serum leptin in psoriasis Herz 37 2012 527 533
43. D.H. O'Leary, and M.L. Bots Imaging of atherosclerosis: carotid intima-media thickness Eur Heart J 31 2010 1682 1689
44. R. Koyoshi, S.I. Miura, N. Kumagai, Y. Shiga, R. Mitsutake, and K. Saku Clinical significance of flow-mediated dilation, brachial intima-media thickness and pulse wave velocity in patients with and without coronary artery disease Circ J 76 2012 1469 1475
45. S. Kervancioglu, V. Davutoglu, A. Ozkur, Y. Sezen, R. Kervancioglu, and M.M. Bayram Carotid and brachial intima-media thickness, arterial diameter and resistivity indices in aortic regurgitation Acta Radiol 45 2004 815 818
46. S. Boehncke, S. Fichtlscherer, R. Salgo, J. Garbaraviciene, H. Beschmann, and S. Diehl Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial Arch Dermatol Res 303 2011 381 388
47. J.M. Gelfand, N.N. Mehta, and S.M. Langan Psoriasis and cardiovascular risk: strength in numbers, part II J Invest Dermatol 131 2011 1007 1010
48. L.T. Jacobsson, C. Turesson, A. Gülfe, M.C. Kapetanovic, I.F. Petersson, and T. Saxne Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis J Rheumatol 32 2005 1213 1218
49. P.J. Little, A. Chait, and A. Bobik Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis Pharmacol Ther 131 2011 255 268
50. J. Channual, J.J. Wu, and F.J. Dann Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis Dermatol Ther 22 2009 61 73